Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 248,360 | 227,960 | 233,300 | 264,474 | 272,867 |
| Cost of Goods | 48,519 | 46,430 | 46,560 | 49,517 | 51,383 |
| Gross Profit | 199,841 | 181,530 | 186,740 | 214,957 | 221,484 |
| Operating Expenses | 173,515 | 159,409 | 164,670 | 186,108 | 188,800 |
| Operating Income | 26,845 | 22,551 | 22,630 | 29,366 | 33,067 |
| Interest Expense | 31 | 32 | 32 | 96 | 32 |
| Other Income | 1,687 | 283 | 626 | 38 | 252 |
| Pre-tax Income | 28,501 | 22,802 | 23,224 | 29,308 | 33,287 |
| Income Tax | 10,118 | 10,007 | 8,295 | 10,151 | 10,818 |
| Net Income Continuous | 18,383 | 12,795 | 14,929 | 19,157 | 22,469 |
| Net Income | $18,383 | $12,795 | $14,929 | $19,157 | $22,469 |
| EPS Basic Total Ops | 0.95 | 0.66 | 0.78 | 1.00 | 1.16 |
| EPS Basic Continuous Ops | 0.95 | 0.67 | 0.78 | 1.00 | 1.16 |
| EPS Diluted Total Ops | 0.95 | 0.66 | 0.78 | 1.00 | 1.15 |
| EPS Diluted Continuous Ops | 0.95 | 0.67 | 0.78 | 1.00 | 1.15 |
| EBITDA(a) | $32,069 | $27,803 | $28,055 | $34,493 | $38,673 |